InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results

Bulletin Express

昨天

InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.

The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.

The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1118885332"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118885332\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118885332?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 17:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118885332","market":"hk","top_or_hot":-1,"title":"InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results","media":"Bulletin Express","content":"<p>InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.</p>\n<p>The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>\n<p>The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-11 17:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.</p>\n<p>The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>\n<p>The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"诺诚健华","start_time":0,"source_url":"","article_id":"1118885332","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118885332","pubTimestamp":1786439384,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"诺诚健华计划于2026年8月24日召开董事会会议，以审阅2026年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.\nThe board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.\nThe meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}